Chronic Kidney Disease
Part of NephTimes
Advertisement
Editorial board chair Dr. Ajay Singh discusses how GFR may vary between sexes and affect rates of CKD.
Elevated glucose uptake in adipose tissue of patients with gout may contribute to CKD progression.
Kidney Care Partners visited called on Congress to support policies benefitting Americans with kidney disease.
AstraZeneca and Aptar Digital Health are partnering on screening algorithms to detect CKD and other conditions.
Study results suggest that psychosocial interventions effectively reduce depression symptoms in people with CKD.
Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD.
An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes.
Fibrate use is associated with higher incidence of CKD but lower risk for ESKD and mortality, a study found.
Iron therapy may reduce cardiovascular risks for patients with chronic kidney disease, a study found.
Rajiv Agarwal discussed a study showing that a finerenone-empagliflozin combo has superior efficacy in CKD and T2D.
Treatment with a finerenone-empagliflozin combo leads to greater decreases in albuminuria in CKD and type 2 diabetes.
A study highlights the role of NPT2b in tubulointerstitial fibrosis and CKD progression.
Finerenone had kidney and cardiovascular benefits for patients with CKD even after an acute eGFR change occurred.
A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.
An analysis of CKD trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Researchers fitted a face mask with a breath sensor that may be able to detect the presence of chronic kidney disease.
A meta-analysis examined the risk of CKD in patients with metabolic dysfunction-associated fatty liver disease.
Researchers sought to quantify the population at risk for pruritus, clinical determinants, and associated adverse outcomes.
A study assessed whether proton pump inhibitor use accelerated CKD progression and acute kidney injury risk.
Joel Topf spoke with dietitian Melanie Betz about potassium, oxalate, and other renal nutrition concerns.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.